Eisai Co., Ltd. (4523.T)
JPY 4271.0
(2.89%)
JPY 4271.0
(2.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -97.93 Billion JPY | 30.67% |
| 2022 | -141.24 Billion JPY | 34.23% |
| 2021 | -214.74 Billion JPY | -35.19% |
| 2020 | -158.84 Billion JPY | 3.32% |
| 2019 | -164.3 Billion JPY | -11.37% |
| 2018 | -147.53 Billion JPY | -51.5% |
| 2017 | -97.38 Billion JPY | -464.75% |
| 2016 | 26.69 Billion JPY | -0.24% |
| 2015 | 26.76 Billion JPY | -57.35% |
| 2014 | 62.74 Billion JPY | -57.59% |
| 2013 | 147.96 Billion JPY | -34.34% |
| 2012 | 225.35 Billion JPY | -6.44% |
| 2011 | 240.86 Billion JPY | -10.3% |
| 2010 | 268.52 Billion JPY | -21.06% |
| 2009 | 340.17 Billion JPY | -8.96% |
| 2008 | 373.63 Billion JPY | 8.28% |
| 2007 | 345.05 Billion JPY | 485.37% |
| 2006 | -89.53 Billion JPY | -21.41% |
| 2005 | -73.75 Billion JPY | -37.81% |
| 2004 | -53.51 Billion JPY | 5.3% |
| 2003 | -56.51 Billion JPY | 44.12% |
| 2002 | -101.12 Billion JPY | -1.88% |
| 2001 | -99.26 Billion JPY | -24.35% |
| 2000 | -79.82 Billion JPY | -156.15% |
| 1999 | -31.16 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -121.6 Billion JPY | -24.17% |
| 2023 Q4 | -97.93 Billion JPY | 17.38% |
| 2023 Q1 | -133.09 Billion JPY | 5.77% |
| 2023 FY | -97.93 Billion JPY | 30.67% |
| 2023 Q2 | -148.22 Billion JPY | -11.37% |
| 2023 Q3 | -118.53 Billion JPY | 20.03% |
| 2022 Q2 | -169.61 Billion JPY | 12.08% |
| 2022 FY | -141.24 Billion JPY | 34.23% |
| 2022 Q3 | -117.88 Billion JPY | 30.5% |
| 2022 Q4 | -141.24 Billion JPY | -19.82% |
| 2022 Q1 | -192.91 Billion JPY | 10.16% |
| 2021 Q3 | -168.49 Billion JPY | 12.74% |
| 2021 FY | -214.74 Billion JPY | -35.19% |
| 2021 Q1 | -120.39 Billion JPY | 24.2% |
| 2021 Q4 | -214.74 Billion JPY | -27.44% |
| 2021 Q2 | -193.09 Billion JPY | -60.38% |
| 2020 Q3 | -103.89 Billion JPY | 24.79% |
| 2020 Q2 | -138.14 Billion JPY | -1.31% |
| 2020 FY | -158.84 Billion JPY | 3.32% |
| 2020 Q1 | -136.35 Billion JPY | 17.01% |
| 2020 Q4 | -158.84 Billion JPY | -52.89% |
| 2019 Q1 | -95.58 Billion JPY | 35.21% |
| 2019 Q2 | -99.97 Billion JPY | -4.59% |
| 2019 Q3 | -98.6 Billion JPY | 1.37% |
| 2019 Q4 | -164.3 Billion JPY | -66.64% |
| 2019 FY | -164.3 Billion JPY | -11.37% |
| 2018 Q2 | -127.88 Billion JPY | -45.8% |
| 2018 Q1 | -87.71 Billion JPY | 9.93% |
| 2018 Q3 | -118.73 Billion JPY | 7.15% |
| 2018 FY | -147.53 Billion JPY | -51.5% |
| 2018 Q4 | -147.53 Billion JPY | -24.26% |
| 2017 Q2 | 43.68 Billion JPY | -30.26% |
| 2017 Q4 | -97.38 Billion JPY | -362.26% |
| 2017 FY | -97.38 Billion JPY | -464.75% |
| 2017 Q1 | 62.63 Billion JPY | 134.61% |
| 2017 Q3 | 37.13 Billion JPY | -15.0% |
| 2016 Q1 | 37.9 Billion JPY | 41.63% |
| 2016 FY | 26.69 Billion JPY | -0.24% |
| 2016 Q4 | 26.69 Billion JPY | -36.93% |
| 2016 Q3 | 42.33 Billion JPY | 118.82% |
| 2016 Q2 | 19.34 Billion JPY | -48.96% |
| 2015 FY | 26.76 Billion JPY | -57.35% |
| 2015 Q1 | 78.32 Billion JPY | 24.83% |
| 2015 Q2 | 56.18 Billion JPY | -28.27% |
| 2015 Q3 | 57.36 Billion JPY | 2.1% |
| 2015 Q4 | 26.76 Billion JPY | -53.35% |
| 2014 Q4 | 62.74 Billion JPY | -39.66% |
| 2014 Q2 | 84.66 Billion JPY | -25.62% |
| 2014 Q1 | 113.83 Billion JPY | -23.07% |
| 2014 Q3 | 103.98 Billion JPY | 22.83% |
| 2014 FY | 62.74 Billion JPY | -57.59% |
| 2013 Q1 | 217.47 Billion JPY | -3.5% |
| 2013 FY | 147.96 Billion JPY | -34.34% |
| 2013 Q2 | 185.78 Billion JPY | -14.57% |
| 2013 Q3 | 173.08 Billion JPY | -6.84% |
| 2013 Q4 | 147.96 Billion JPY | -14.51% |
| 2012 FY | 225.35 Billion JPY | -6.44% |
| 2012 Q1 | 247.02 Billion JPY | 2.56% |
| 2012 Q4 | 225.35 Billion JPY | -13.48% |
| 2012 Q3 | 260.47 Billion JPY | 7.47% |
| 2012 Q2 | 242.38 Billion JPY | -1.88% |
| 2011 FY | 240.86 Billion JPY | -10.3% |
| 2011 Q3 | 259.26 Billion JPY | 8.32% |
| 2011 Q1 | 269.54 Billion JPY | 0.38% |
| 2011 Q4 | 240.86 Billion JPY | -7.1% |
| 2011 Q2 | 239.34 Billion JPY | -11.21% |
| 2010 Q1 | 329.69 Billion JPY | -3.08% |
| 2010 FY | 268.52 Billion JPY | -21.06% |
| 2010 Q4 | 268.52 Billion JPY | -10.1% |
| 2010 Q2 | 293.04 Billion JPY | -11.12% |
| 2010 Q3 | 298.69 Billion JPY | 1.93% |
| 2009 Q2 | 362.54 Billion JPY | -4.12% |
| 2009 Q4 | 340.17 Billion JPY | -10.21% |
| 2009 FY | 340.17 Billion JPY | -8.96% |
| 2009 Q3 | 378.84 Billion JPY | 4.5% |
| 2009 Q1 | 378.1 Billion JPY | 1.19% |
| 2008 Q4 | 373.63 Billion JPY | 0.0% |
| 2008 FY | 373.63 Billion JPY | 8.28% |
| 2007 FY | 345.05 Billion JPY | 485.37% |
| 2006 FY | -89.53 Billion JPY | -21.41% |
| 2005 FY | -73.75 Billion JPY | -37.81% |
| 2004 FY | -53.51 Billion JPY | 5.3% |
| 2003 FY | -56.51 Billion JPY | 44.12% |
| 2002 FY | -101.12 Billion JPY | -1.88% |
| 2001 FY | -99.26 Billion JPY | -24.35% |
| 2000 FY | -79.82 Billion JPY | -156.15% |
| 1999 FY | -31.16 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 8094.449% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 102.233% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 125.121% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 71.734% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -2647.72% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -132.309% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | -59.306% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -14582.459% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | -88.981% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -197.476% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 1388.24% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 1358.604% |
| Tsumura & Co. | 1.61 Billion JPY | 6163.901% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | -121.766% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -184.38% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 156.704% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 467.834% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 437.909% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 1487.139% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 14010.795% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 1734.379% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -1402.714% |
| MedRx Co., Ltd | -1.72 Billion JPY | -5593.721% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -1023.529% |
| Solasia Pharma K.K. | -668 Million JPY | -14560.479% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -6557.797% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -1250.227% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 273.264% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -3207.65% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 0.505% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -779.924% |